• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病患者动脉内和静脉内注射前列腺素E1的血流动力学效应。

Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.

作者信息

Hirai M, Nakayama R

出版信息

Br J Surg. 1986 Jan;73(1):20-3. doi: 10.1002/bjs.1800730109.

DOI:10.1002/bjs.1800730109
PMID:3947867
Abstract

The purpose of this study was to compare the haemodynamic effects of intra-arterial and intravenous prostaglandin E1 (PGE1) both injected and infused into ischaemic legs. Continuous intra-arterial infusion of PGE1 induced a significantly greater increase in skin temperature and blood flow than did intravenous drip infusion. Furthermore, intra-arterial infusion caused no steal phenomenon in the toe as indicated by skin temperature. On the other hand, toe skin temperature decreased during intravenous drip in 33 per cent of the legs tested. Continuous intravenous infusion also produced a significantly greater increase in toe skin temperature than did brief intravenous drip. In three of ten ulcers healed by continuous intra-arterial infusion, no definitive effect was obtained from continuous intravenous infusion even when it was repeated up to three times before continuous intra-arterial infusion. Intra-arterial injection of PGE1 caused no significant increase in toe skin temperature.

摘要

本研究的目的是比较经动脉和经静脉注射及输注前列腺素E1(PGE1)对缺血肢体的血流动力学影响。持续经动脉输注PGE1比静脉滴注能显著提高皮肤温度和血流量。此外,经动脉输注未导致趾部出现皮温所示的窃血现象。另一方面,在33%的受试肢体中,静脉滴注期间趾部皮肤温度下降。持续静脉输注比短暂静脉滴注也能使趾部皮肤温度显著升高。在经持续动脉输注愈合的10处溃疡中,有3处即使在持续动脉输注前重复静脉输注多达3次,也未获得确切效果。动脉注射PGE1未使趾部皮肤温度显著升高。

相似文献

1
Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.外周动脉疾病患者动脉内和静脉内注射前列腺素E1的血流动力学效应。
Br J Surg. 1986 Jan;73(1):20-3. doi: 10.1002/bjs.1800730109.
2
Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Angiology. 1995 May;46(5):357-67. doi: 10.1177/000331979504600501.
3
Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.对患有外周动脉闭塞性疾病的患者,动脉内和静脉内给予前列腺素E1会引起皮肤微循环的不同变化。
Vasa. 1998 May;27(2):100-5.
4
Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.静脉注射前列腺素E1对下肢动脉闭塞性疾病患者的血流动力学影响。
Angiology. 1985 Jul;36(7):407-13. doi: 10.1177/000331978503600701.
5
Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.外周血管疾病中前列腺素E1:一项关于肌肉血流的正电子发射断层扫描研究
Scand J Clin Lab Invest. 1998 Apr;58(2):109-17. doi: 10.1080/00365519850186689.
6
Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.脂微球载体前列腺素E1,一种新型的前列腺素E1脂质包裹制剂:糖尿病性神经病变和腿部溃疡患者的安慰剂对照及前列腺素E1对照多中心试验
Prostaglandins. 1993 Nov;46(5):453-68. doi: 10.1016/0090-6980(93)90081-h.
7
[Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].[动脉内和静脉内输注前列腺素E1对肢体严重缺血患者经皮氧分压的影响]
Vasa Suppl. 1991;33:341-2.
8
[Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Vasa Suppl. 1988;23:121-5.
9
Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.外周动脉闭塞性疾病中的中性粒细胞功能:前列腺素E1的作用。
Vasc Med. 1998;3(3):171-5. doi: 10.1177/1358836X9800300301.
10
Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.动脉内注射前列腺素E1对周围动脉闭塞性疾病患者的影响。
Eur J Clin Invest. 1986 Dec;16(6):480-5. doi: 10.1111/j.1365-2362.1986.tb02165.x.

引用本文的文献

1
Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.用于长循环的前列腺素E1聚乙二醇化纳米乳剂的研发、优化及表征
AAPS PharmSciTech. 2016 Apr;17(2):409-17. doi: 10.1208/s12249-015-0366-1. Epub 2015 Jul 21.
2
Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.静脉输注后健康志愿者中前列地尔(前列腺素E1)的剂量比例药代动力学。
Br J Clin Pharmacol. 1995 Sep;40(3):273-6. doi: 10.1111/j.1365-2125.1995.tb05784.x.
3
Current surgery/drug combination treatment of diabetic gangrene of the foot.
糖尿病足坏疽的当前手术/药物联合治疗。
Infection. 1991;19 Suppl 6:S351-4. doi: 10.1007/BF01715777.